New York, NY -- (SBWIRE) -- 01/09/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: ARMOUR Residential REIT, Inc.(NYSE:ARR),Frontline Ltd(NYSE:FRO), Chelsea Therapeutics International Ltd.(NASDAQ:CHTP),Delcath Systems, Inc.(NASDAQ:DCTH)
ARMOUR Residential REIT, Inc.(NYSE:ARR) reported gain 0.24% and closed at $4.12 with the total traded volume of 4.40M shares. Its market capitalization is $1.53B. The stock has a 52-week high price of 7.19 and its 52-week low was recorded at $3.64.
ARMOUR Residential REIT, Inc.( ARMOUR) is an externally-managed Maryland corporation managed by ARMOUR Residential REIT, Inc.
What ARR Charts Are Signaling for Traders? Find Out Here
Frontline Ltd(NYSE:FRO) gain 5.73% and ended at $4.61.The total traded volume was 4.37M shares and market capitalization arrived at $363.47M. The stock has a 52-week high price of $4.78 and its 52-week low was recorded at $1.71, while during last trade its minimum price was $4.40 and it gained the highest price of $4.78.
Frontline Ltd. is a Bermuda-based shipping company engaged primarily in the ownership and operation of oil tanker. The Company operates oil tankers of two sizes: Very Large Crude Carriers (VLCCs), which are between 200,000 and 320,000 deadweight tonnages (dwt), and Suezmax tankers, which are vessels between 120,000 and 170,000 dwt.
Is FRO Buy After The Recent Price Movement? Find Out Here
Chelsea Therapeutics International Ltd.(NASDAQ:CHTP)’s reported the loss -3.03% to close at $3.20 with the overall traded volume of 4.33M shares. Its market capitalization on last close reached to $250.99 million. Its intraday-low price was $3.14 and its hit its day's highest price at $3.30.
Chelsea Therapeutics International, Ltd. is a development stage pharmaceutical company that focuses on acquiring, developing and commercializing products for the treatment of a variety of human diseases.
Should CHTP a Buy or Sell Now? Find Out Here
Delcath Systems, Inc.(NASDAQ:DCTH) unchanged settle at $0.278. Its total traded volume during last trading session was 4.28M shares. The overall market worth of this company is about $35.11M. The 52 week range of the stock remained $0.22- $2.19, while its day's lowest price was $0.274 and its hit its day's highest price at $0.29.
Delcath Systems, Inc. (Delcath) is a development-stage, specialty pharmaceutical and medical device company, focused on oncology, initially cancers in the liver. Delcath focuses on the development and clinical study of the Delcath chemosaturation system
What DCTH Charts Are Signaling for Traders? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)